Schafer Cullen Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Schafer Cullen Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-338,979	Closed	-$21M	–	75
2020 Q4	$21M	Buy	338,979 +223,296	+193%	+$13.7M	0.31%	75
2020 Q3	$6.97M	Sell	115,683 -3,128	-3%	-$188K	0.11%	91
2020 Q2	$6.99M	Sell	118,811 -4	-0%	-$239	0.11%	92
2020 Q1	$6.62M	Sell	118,815 -13,235	-10%	-$809K	0.11%	96
2019 Q4	$8.48M	Sell	132,050 -4,100	-3%	-$235K	0.1%	101
2019 Q3	$6.9M	Buy	+136,150	New	+$6.4M	0.08%	102
2013 Q3	–	Sell	-5,030	Closed	-$225K	–	334
2013 Q2	$225K	Buy	+5,030	New	+$218K	﹤0.01%	294

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Schafer Cullen Capital Management's BMY Position: Q1 2021 in Review

Schafer Cullen Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 338,979 shares — an estimated $21M sold.

Schafer Cullen Capital Management first reported a position in BMY in Q2 2013 and held it in 7 quarters. The position peaked at $21M in Q4 2020. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

Schafer Cullen Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
Schafer Cullen Capital Management sold 338,979 Bristol-Myers Squibb shares in Q1 2021, an estimated $21M.
Schafer Cullen Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 7 quarters.
Schafer Cullen Capital Management's Bristol-Myers Squibb position peaked at $21M in Q4 2020.
2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Schafer Cullen Capital Management's 13F filing for Q1 2021, filed 10 May 2021.